Abiopharma

🔍 Neal Stephen C (Director)

Company: NVIDIA CORP (NVDA)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Acquired 1,211 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,098.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: The Neal/Rhyu Revocable Trust dated 5/2/2017 | shares_owned_after: 116,135.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: 2013 Stephen C. Neal Revocable Trust | shares_owned_after: 42,203.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: 2013 Michelle S. Rhyu Revocable Trust | shares_owned_after: 7,142.00 | Footnotes: F4

Footnotes:

• F1: Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 18, 2026 and 50% of the shares on May 19, 2027. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested.
• F2: Shares held by The Neal/Rhyu Revocable Trust dated 5/2/2017, of which the Reporting Person is trustee.
• F3: Shares held by 2013 Stephen C. Neal Revocable Trust, of which the Reporting Person is trustee.
• F4: Shares held by 2013 Michelle S. Rhyu Revocable Trust.